Health Care Interrupted: Research Frontiers Beckon
The answers to how clinical care was affected by the pandemic could change the practice of medicine.
Diagnosis & Disease Information
Dapagliflozin Slows FSGS Progression
Dapagliflozin, an oral SGLT2 inhibitor, decreased the risk of progression of focal segmental glomerulosclerosis compared with placebo, a subgroup analysis of the DAPA-CKD trial showed.
High, Low Uric Acid Levels Increase Chronic Kidney Disease Risk
In a study of middle-aged adults, serum uric acid levels less than 4.0 and 10.0 mg/dL or higher in men and less than 4.0 and 8.0 mg/dL or higher in women were significantly associated with increased risks for chronic kidney disease.
SARS-CoV-2 Infection Linked to Greater Decline in Kidney Allograft Function
Patients with moderate and severe infection experienced a 17.50% and 23.16% decrease in estimated glomerular filtration rate (eGFR), respectively, from baseline (before testing positive for SARS-CoV-2) to 90 days after the positive test.
Pembrolizumab After RCC Surgery: Potential New Standard of Care
In the randomized phase 3 KEYNOTE-564 trial, pembrolizumab treatment after nephrectomy for clear cell RCC was associated with a 32% decreased risk of cancer recurrence or death compared with placebo.
Targeted Radiotherapy Improves Outcomes in Previously Treated mCRPC
An investigational targeted radiotherapy added to standard of care improved survival in men with previously treated mCRPC.
Prostate Cancer Care Declined During the COVID-19 Pandemic
How the decline in health care visits will affect prostate cancer outcomes still needs to be determined.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...